[ad_1]
Screening News – Agencies – Experts in Russia have developed medical preparations for the treatment of hepatitis B, which can destroy viruses to cure the patient of this chronic disease.
Preclinical trials of these drugs should begin in 2019. If successful, you will be prescribed to patients within five years. "Until recently, the destruction of the genome was not technically feasible," said Vladimir Chulanov, head of the research and scientific research department of the Center for Epidemiological Research. "The effect of the drugs we have developed is based on the new CRISPR / Cas9 systems.
The vaccine has been present since 1982 and has been shown to be effective against 95% hepatitis B.
[ad_2]
Source link
